Select Country

Please select a country, so we can supply you with the most accurate content available for your country or region.

  • Login / Sign Up
    • My Quote
    Cart

    MP Biomedicals Announces Launch of SARS-CoV-2 Products

    March 31, 2020
    MP Biomedicals, a division of Valiant Co., Ltd., is stepping in to support scientists worldwide in understanding SARS-CoV-2 and discovering solutions to combat COVID-19. We have launched several new monoclonal antibodies and recombinant antigens to help accelerate the fundamental research and development of critical diagnostic tools.

    Our monoclonal antibodies from mouse have high affinity to the SARS-CoV-2 spike proteins for use in various applications, including western blot, immunoprecipitation, ELISA tests, rapid tests and flow cytometry. MP Biomedicals’ selection of recombinant protein antigens for coronavirus are expressed in E. coli and HEK293 cells and include the spike protein, host receptor ACE2, and the nucleocapsid protein.

    Learn More.
    < Back to News